![](/img/cover-not-exists.png)
144. Fabry nephropathy (FN) and the agalsidase beta and ARBs and ACE inhibitor treatment (FAACET) study: Determinants of proteinuria during the titration phase
David G. Warnock, Leslie Jackson, Christie Thomas, Emily Phillips, Tony Guasch, Dawn A. Laney, Joel Charrow, Shanna WideraVolume:
99
Year:
2010
Language:
english
DOI:
10.1016/j.ymgme.2009.10.161
File:
PDF, 44 KB
english, 2010